We are live on
!
Find out more
CBU
CIBC Bancorp USA Portfolio holdings
AUM
$82.3B
This Fund
S&P 500
This Quarter
Est. Return
+20.02%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$82.3B
AUM Growth
+$7.86B
(+11%)
Cap. Flow
-$944M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
26.31%
Holding
2,056
New
305
Increased
737
Reduced
780
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DraftKings
DKNG
|
+$619M |
| 2 |
Flutter Entertainment
FLUT
|
+$527M |
| 3 |
Micron Technology
MU
|
+$319M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$297M |
| 5 |
Robinhood
HOOD
|
+$197M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$418M |
| 3 |
Amazon
AMZN
|
+$411M |
| 4 |
Microsoft
MSFT
|
+$358M |
| 5 |
Apple
AAPL
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.78% |
| 2 | Financials | 10.07% |
| 3 | Industrials | 10.04% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Healthcare | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Recursion Pharmaceuticals
RXRX
$1.69B
| $104K | ﹤0.01% |
28,405
+5,320
| +23% | +$17.7K |
|
1852
Novavax
NVAX
$1.33B
| $101K | ﹤0.01% |
10,728
-619
| -5% | -$5.55K |
|
1853
Butterfly Network
BFLY
$2.35B
| $98.3K | ﹤0.01% |
11,669
-6,002
| -34% | -$31.1K |
|
|
TE
1854
T1 Energy
TE
$1.51B
| $97K | ﹤0.01% |
10,231
-10
| -0.1% | -$71 |
|
1855
Prairie Operating Co
PROP
$97.7M
| $96K | ﹤0.01% |
132,987
-11,632
| -8% | -$12.5K |
|
1856
AtaiBeckley Inc
ATAI
$2.69B
| $94.8K | ﹤0.01% |
+17,989
| New | +$75.7K |
|
1857
DXC Technology
DXC
$1.72B
| $94.8K | ﹤0.01% |
+10,709
| New | +$111K |
|
1858
Teladoc Health
TDOC
$1.24B
| $93.9K | ﹤0.01% |
11,070
+674
| +6% | +$4.49K |
|
1859
Hillman Solutions
HLMN
$1.69B
| $93.8K | ﹤0.01% |
11,119
+931
| +9% | +$7.4K |
|
1860
Geron
GERN
$943M
| $93.4K | ﹤0.01% |
72,971
+3,466
| +5% | +$4.88K |
|
1861
Iovance Biotherapeutics
IOVA
$3.16B
| $91.7K | ﹤0.01% |
22,044
+5,056
| +30% | +$19.2K |
|
1862
Taysha Gene Therapies
TSHA
$1.94B
| $90.3K | ﹤0.01% |
13,262
+2,141
| +19% | +$12.7K |
|
1863
SIGA Technologies
SIGA
$216M
| $86.1K | ﹤0.01% |
23,650
+266
| +1% | +$1.19K |
|
1864
Genius Sports
GENI
$2.33B
| $82.9K | ﹤0.01% |
13,685
+2,292
| +20% | +$11.9K |
|
1865
Aware
AWRE
$26.4M
| $81K | ﹤0.01% |
60,000
| – | – |
|
|
TIC
1866
TIC Solutions Inc
TIC
$2.15B
| $81K | ﹤0.01% |
10,010
-178
| -2% | -$1.5K |
|
1867
Destination XL Group
DXLG
$35.4M
| $80.4K | ﹤0.01% |
120,000
-220,000
| -65% | -$145K |
|
|
ORC
1868
Orchid Island Capital
ORC
$1.32B
| $79.2K | ﹤0.01% |
+11,364
| New | +$78.3K |
|
1869
Nuvation Bio
NUVB
$2.18B
| $79K | ﹤0.01% |
13,916
+770
| +6% | +$3.76K |
|
1870
Marqeta
MQ
$1.7B
| $78.6K | ﹤0.01% |
4,839
+325
| +7% | +$5.28K |
|
1871
Kosmos Energy
KOS
$1.51B
| $78.5K | ﹤0.01% |
37,189
+12,965
| +54% | +$36.1K |
|
1872
Anixa Biosciences
ANIX
$108M
| $74.5K | ﹤0.01% |
26,600
| – | – |
|
1873
PUT
Array Technologies
ARRY
$778M
| $74.1K | ﹤0.01% |
+10,000
| New | +$79.7K |
|
1874
Vaalco Energy
EGY
$608M
| $73.4K | ﹤0.01% |
14,458
+543
| +4% | +$3.13K |
|
1875
MannKind Corp
MNKD
$1.24B
| $72.4K | ﹤0.01% |
16,998
+1,591
| +10% | +$5.17K |
|
Similar funds
QCM
CIBC Bancorp USA's Q2 2026 Portfolio in Review
As of Q2 2026, CIBC Bancorp USA held 2,056 positions worth $82.3B, up 11% from $74.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
CIBC Bancorp USA's Q2 2026 filing shows 305 new, 737 increased, 780 reduced and 129 closed positions. Its largest new stake was iShares MSCI Brazil ETF: 1,937,500 shares worth $66.8M. The largest sale was NVIDIA, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
- CIBC Bancorp USA's largest Q2 2026 buy was iShares MSCI Brazil ETF: 1,937,500 shares worth $66.8M.
- CIBC Bancorp USA added most to DraftKings in Q2 2026, an estimated $619M increase.
- CIBC Bancorp USA's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $474M.
- CIBC Bancorp USA fully exited Bio-Rad Laboratories Class A in Q2 2026, selling an estimated $33.5M.
- CIBC Bancorp USA's ten largest holdings make up 26% of its $82.3B portfolio in Q2 2026.
- CIBC Bancorp USA opened 305 new positions and closed 129 in Q2 2026.
- CIBC Bancorp USA's portfolio value rose 11% quarter-over-quarter to $82.3B.
Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.